middle.news
Orthocell Boosts Cash by $3M to Accelerate Nerve Repair Product Rollout
1:12pm on Wednesday 18th of February, 2026 AEDT
•
Healthcare
Read Story
Orthocell Boosts Cash by $3M to Accelerate Nerve Repair Product Rollout
1:12pm on Wednesday 18th of February, 2026 AEDT
Key Points
Received $3 million R&D tax refund from Australian Government
Cash reserves now total $49.6 million, with zero debt
Funding supports commercial expansion of Remplir™ in Americas and Asia Pacific
Ongoing investment in clinical evidence and medical education
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE